Russell Investments Group
NEO icon

Russell Investments Group’s NeoGenomics NEO Stock Holding History

Russell Investments Group’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$967K Buy
66,283
+56,446
+574% +$545K ﹤0.01% 2479
2026
Q1 		$73K Sell
9,837
-396
-4% -$4.17K ﹤0.01% 3185
2025
Q4 		$120K Sell
10,233
-458
-4% -$4.94K ﹤0.01% 2994
2025
Q3 		$82.5K Buy
10,691
+10,131
+1,809% +$71K ﹤0.01% 3093
2025
Q2 		$4.09K Sell
560
-640
-53% -$5.17K ﹤0.01% 3492
2025
Q1 		$11.4K Sell
1,200
-621
-34% -$7.75K ﹤0.01% 3216
2024
Q4 		$30K Buy
1,821
+201
+12% +$3.12K ﹤0.01% 2937
2024
Q3 		$23.9K Sell
1,620
-8,020
-83% -$125K ﹤0.01% 2923
2024
Q2 		$134K Buy
9,640
+5,299
+122% +$75.1K ﹤0.01% 2563
2024
Q1 		$68.2K Sell
4,341
-142,284
-97% -$2.2M ﹤0.01% 2617
2023
Q4 		$2.37M Buy
146,625
+146,604
+698,114% +$2.4M ﹤0.01% 1526
2023
Q3 		$258 Buy
+21
New +$312 ﹤0.01% 3459
2023
Q2 		– Sell
-23
Closed -$400 – 3505
2023
Q1 		$400 Sell
23
-18,145
-100% -$258K ﹤0.01% 3179
2022
Q4 		$168K Hold
18,168
– – ﹤0.01% 2602
2022
Q3 		$156K Hold
18,168
– – ﹤0.01% 2598
2022
Q2 		$148K Sell
18,168
-208,128
-92% -$1.99M ﹤0.01% 2601
2022
Q1 		$2.75M Sell
226,296
-12,183
-5% -$256K ﹤0.01% 1474
2021
Q4 		$8.14M Sell
238,479
-429
-0.2% -$16.8K 0.01% 1009
2021
Q3 		$11.5M Sell
238,908
-55,019
-19% -$2.55M 0.02% 821
2021
Q2 		$13.3M Buy
293,927
+74,478
+34% +$3.3M 0.02% 786
2021
Q1 		$10.6M Buy
219,449
+65,862
+43% +$3.43M 0.02% 909
2020
Q4 		$8.27M Sell
153,587
-104,424
-40% -$4.72M 0.02% 967
2020
Q3 		$9.52M Sell
258,011
-19,420
-7% -$722K 0.02% 792
2020
Q2 		$8.59M Sell
277,431
-22,895
-8% -$634K 0.02% 809
2020
Q1 		$8.29M Sell
300,326
-211,489
-41% -$6.34M 0.02% 725
2019
Q4 		$15M Sell
511,815
-55,190
-10% -$1.31M 0.03% 667
2019
Q3 		$10.8M Sell
567,005
-41,896
-7% -$983K 0.02% 819
2019
Q2 		$13.4M Sell
608,901
-22,209
-4% -$487K 0.02% 735
2019
Q1 		$12.9M Sell
631,110
-436,498
-41% -$7.59M 0.02% 764
2018
Q4 		$13.4M Sell
1,067,608
-588,616
-36% -$8.77M 0.03% 674
2018
Q3 		$25.4M Sell
1,656,224
-805,994
-33% -$11.1M 0.05% 465
2018
Q2 		$32.3M Sell
2,462,218
-213,790
-8% -$2.35M 0.07% 328
2018
Q1 		$21.8M Buy
2,676,008
+40,521
+2% +$328K 0.04% 568
2017
Q4 		$23.5M Buy
2,635,487
+138,864
+6% +$1.28M 0.04% 571
2017
Q3 		$27.8M Buy
2,496,623
+499,913
+25% +$4.87M 0.05% 467
2017
Q2 		$17.9M Buy
1,996,710
+794,281
+66% +$6.3M 0.03% 649
2017
Q1 		$9.49M Sell
1,202,429
-322,077
-21% -$2.62M 0.02% 901
2016
Q4 		$13.3M Buy
+1,524,506
New +$13.1M 0.03% 718

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
GIP
Granite Investment Partners El Segundo, California $1.95B AUM 49.89% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return
HCA
Harbor Capital Advisors Chicago, Illinois $1.47B AUM 42.58% 1-Year Est. Return

Russell Investments Group's NEO Position: Q2 2026 in Review

Russell Investments Group increased its NeoGenomics (NEO) stake by 574% in Q2 2026, buying an estimated $545K and bringing the position to 66,283 shares worth $967K. The position accounts for ﹤0.01% of the portfolio, ranked #2479.

Russell Investments Group first reported a position in NEO in Q4 2016 and has held it in 38 quarters since. The position peaked at $32.3M in Q2 2018. 95 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • Russell Investments Group held 66,283 shares of NeoGenomics worth $967K as of Q2 2026.
  • Russell Investments Group bought 56,446 NeoGenomics shares in Q2 2026, an estimated $545K.
  • NeoGenomics made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #2479 holding.
  • Russell Investments Group first reported a position in NeoGenomics in Q4 2016 and has held it in 38 quarters since.
  • Russell Investments Group's NeoGenomics position peaked at $32.3M in Q2 2018.
  • 95 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.